By Ana Ayala*, Anthony Brown, Emanuele Cesta, Katherine Ginsbach, Sam Halabi, Dawn Mapatano*
In a public health emergency, pharmaceutical manufacturers’ liability concerns can slow the deployment of urgently needed vaccines and other medical countermeasures (MCMs).